PURPOSE
This prospective, blinded study was designed to assess intraperitoneal cytokine productions and their relationship to clinical presentations and systemic inflammatory markers in patients with inflammatory bowel disease.
METHODS
Fifty patients who required abdominal surgery for active inflammatory bowel disease (ulcerative colitis, 27; and Crohn’s disease, 23) were investigated. Interleukin-1β, interleukin-6, and tumor necrosis factor-α levels in intraperitoneal fluid (obtained by intraoperative lavage) and plasma were measured by enzyme-linked immunosorbent assay. To compare intraperitoneal cytokine productions between diseases with a different degree of inflammation, intraperitoneal cytokine measurement also was performed for patients who required surgery for colorectal cancer (n = 25) and acute appendicitis (n = 25).
RESULTS
The median intraperitoneal cytokine (interleukin-1β, interleukin-6, and tumor necrosis factor-α) levels were significantly higher in patients with inflammatory bowel disease than in patients with colorectal cancer and acute appendicitis. In patients with inflammatory bowel disease, intraperitoneal cytokine levels were significantly higher in patients with intraperitoneal sepsis (abscess/fistula) than in patients without intraperitoneal sepsis at laparotomy. Intraperitoneal cytokine levels did not correlate with type of disease (ulcerative colitis/Crohn’s disease), age, gender, duration of disease before surgery, preoperative medical treatment, and the extent or site of disease. There were no significant correlations between intraperitoneal cytokine levels and the following systemic inflammatory markers: plasma cytokine levels, white blood cell count, platelet count, erythrocyte sedimentation rate, and C-reactive protein levels. Postoperative intraperitoneal septic complications (anastomotic leak/abscess/enterocutaneous fistula) more frequently occurred in patients with higher intraperitoneal cytokine levels.
CONCLUSIONS
Intraperitoneal cytokine productions were greatly elevated in patients with inflammatory bowel disease, and their levels correlated with the presence of intraperitoneal sepsis at laparotomy and development of postoperative intraperitoneal septic complications. Intraperitoneal cytokine levels showed no correlations with systemic inflammatory markers.
Similar content being viewed by others
REFERENCES
M Ligumsky PL Simon F Karmeli D Rachmilewitz (1989) ArticleTitleRole of interleukin 1 in inflammatory bowel disease-enhanced production during active disease Gut 31 686–9
YR Mahida K Wu DP Jewell (1989) ArticleTitleEnhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn’s disease Gut 30 835–8 Occurrence Handle1:CAS:528:DyaL1MXkslKgsrg%3D Occurrence Handle2787769
WE Pullman S Elsbury M Kobayashi AJ Hapel WF Doe (1992) ArticleTitleEnhanced mucosal cytokine production in inflammatory bowel disease Gastroenterology 102 529–37 Occurrence Handle1:STN:280:DyaK387itVersA%3D%3D Occurrence Handle1370662
J-M Reimund C Wittersheim S Dumont et al. (1996) ArticleTitleIncreased production of tumour necrosis factor-α, interleukin-1β, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn’s disease Gut 39 684–9 Occurrence Handle1:STN:280:DyaK2s7nsFCltQ%3D%3D Occurrence Handle9026483
V Gross T Andus I Ceasar M Roth J Schoelmerich (1992) ArticleTitleEvidence for continuous stimulation of interleukin-6 production in Crohn’s disease Gastroenterology 102 514–9 Occurrence Handle1:STN:280:DyaK387itVersg%3D%3D Occurrence Handle1370661
C Niederau F Backmerhoff B Schumacher N Christoph (1997) ArticleTitleInflammatory mediators and acute phase proteins in patients with Crohn’s disease and ulcerative colitis Hepatogastroenterology 44 90–107 Occurrence Handle1:STN:280:DyaK2s3htFWhug%3D%3D Occurrence Handle9058126
M Maeda N Watanabe H Neda et al. (1992) ArticleTitleSerum tumor necrosis factor activity in inflammatory bowel disease Immunopharmacol Immunotoxicol 14 451–61 Occurrence Handle1:STN:280:DyaK38zovVGksA%3D%3D Occurrence Handle1517530
L Hultén (1988) ArticleTitleSurgical treatment of Crohn’s disease of the small bowel or ileocecum World J Surg 12 180–5 Occurrence Handle3293325
T Yamamoto RN Allan MR Keighley (2000) ArticleTitleRisk factors for intra-abdominal sepsis after surgery in Crohn’s disease Dis Colon Rectum 43 1141–5 Occurrence Handle1:STN:280:DC%2BD3cvitVSnsA%3D%3D Occurrence Handle10950014
KA Heel JC Hall (1996) ArticleTitlePeritoneal defences and peritoneum-associated lymphoid tissue Br J Surg 83 1031–6 Occurrence Handle1:STN:280:DyaK2s%2Fit12guw%3D%3D Occurrence Handle8869299
FP Wu C Sietses BM von PA van Leeuwen S Meijer MA Cuesta (2003) ArticleTitleSystemic and peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial Dis Colon Rectum 46 147–55 Occurrence Handle1:STN:280:DC%2BD3s%2Fms1aitA%3D%3D Occurrence Handle12576886
D Zemel GC Koomen AA Hart IJ ten Berge DG Struijk RT Krediet (1993) ArticleTitleRelationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis J Lab Clin Med 122 686–96 Occurrence Handle1:STN:280:DyaK2c%2FmsFClsg%3D%3D Occurrence Handle8245688
D Zemel RT Krediet GC Koomen et al. (1994) ArticleTitleInterleukin-8 during peritonitis in patients treated with CAPD: an in-vivo model of acute inflammation Nephrol Dial Transplant 9 169–74 Occurrence Handle1:STN:280:DyaK2c3kslOjtQ%3D%3D Occurrence Handle8190331
SC Truelove LJ Witts (1955) ArticleTitleCortisone in ulcerative colitis. Final report on a therapeutic trial BMJ 2 1041–4 Occurrence Handle13260656 Occurrence Handle1:STN:280:DyaG28%2Fht1Gksg%3D%3D Occurrence Handle10.1136/bmj.2.4947.1041
D Rachmilewitz (1989) ArticleTitleCoated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial BMJ 298 82–6 Occurrence Handle1:STN:280:DyaL1M7ltVOitg%3D%3D Occurrence Handle2563951
WR Best JM Becktel JW Singleton F Kern SuffixJr (1976) ArticleTitleDevelopment of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study Gastroenterology 70 439–44 Occurrence Handle1:STN:280:DyaE287hvVGmtg%3D%3D Occurrence Handle1248701
FA Rivera-Chavez H Wheeler G Lindberg RS Munford GE O’Keefe (2002) ArticleTitleRegional and systemic cytokine responses to acute inflammation of the vermiform appendix Ann Surg 237 408–16
MM Bradford (1976) ArticleTitleA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248–54 Occurrence Handle1:CAS:528:DyaE28XksVehtrY%3D Occurrence Handle942051
RG Holzheimer M Schein DH Wittmann (1995) ArticleTitleInflammatory response in peritoneal exudates and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis Arch Surg 130 1314–20 Occurrence Handle1:STN:280:DyaK28%2FpsV2ltg%3D%3D Occurrence Handle7492280
R Herwig B Glodny C Kuhle et al. (2002) ArticleTitleEarly identification of peritonitis by peritoneal cytokine measurement Dis Colon Rectum 45 514–21 Occurrence Handle12006934
YR Mahida L Kurlac A Gallagher CJ Hawkey (1991) ArticleTitleHigh circulating concentrations of interleukin-6 in active Crohn’s disease but not ulcerative colitis Gut 32 1531–4 Occurrence Handle1:STN:280:DyaK387ivVOrsg%3D%3D Occurrence Handle1773961
T Matsuura GA West JS Kleins L Ferraris L Fiocchi (1992) ArticleTitleSoluble interleukin-2 and CD8 and CD4 receptors in inflammatory bowel disease Gastroenterology 102 2006–14 Occurrence Handle1:STN:280:DyaK383mslejsQ%3D%3D Occurrence Handle1587419
RS Kaczmarski GJ Mufti (1991) ArticleTitleThe cytokine receptor superfamily Blood Rev 5 193–203 Occurrence Handle1:STN:280:DyaK387js1SjsQ%3D%3D Occurrence Handle1663810
WP Arend (1993) ArticleTitleInterleukin-1 receptor antagonist Adv Immunol 54 167–227 Occurrence Handle1:CAS:528:DyaK3sXms1yitb8%3D Occurrence Handle8379462 Occurrence Handle10.1016/S0065-2776(08)60535-0
KM McMasters WG Cheadle (1993) ArticleTitleRegulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent J Surg Res 54 426–30 Occurrence Handle1:CAS:528:DyaK2cXhtVClsrw%3D Occurrence Handle8361168
L Shapiro JA Gelfand (1993) ArticleTitleCytokines and sepsis: pathology and therapy New Horiz 1 13–22 Occurrence Handle1:STN:280:DyaK2M%2Fgs1OjtA%3D%3D Occurrence Handle7922386
R van Furth TL van Zwet AM Buisman JT van Dissel (1994) ArticleTitleAnti-tumor necrosis antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudates and enhance the growth of Listeria monocytogenes in various organs J Infect Dis 170 234–7 Occurrence Handle1:CAS:528:DyaK2cXlsFGhsLc%3D Occurrence Handle8014508
TJ Schall K Bacon KJ Toy DV Goeddel (1990) ArticleTitleSelective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES Nature 347 669–71 Occurrence Handle1:CAS:528:DyaK3cXmtV2ru7g%3D Occurrence Handle1699135
M Sticherling F Hetzel JM Schroder E Christophers (1993) ArticleTitleTime- and stimulus-dependent secretion of NAP-1/IL-8 by human fibroblasts and endothelial cells J Invest Dermatol 101 573–6 Occurrence Handle1:CAS:528:DyaK3sXms1yltL0%3D Occurrence Handle8409526
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yamamoto, T., Umegae, S., Kitagawa, T. et al. Intraperitoneal Cytokine Productions and Their Relationship to Peritoneal Sepsis and Systemic Inflammatory Markers in Patients With Inflammatory Bowel Disease. Dis Colon Rectum 48, 1005–1015 (2005). https://doi.org/10.1007/s10350-004-0866-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-0866-7